Isorif Tablets BP 300 mg + 150 mg Exporter in India – Healthy Inc

Isorif Tablets BP 300 mg + 150 mg | Exporter
Product image for Isorif Tablets BP 300 mg + 150 mg Exporter; regulatory dossiers & international shipping.
Product Information
| Generic Name | Isorif |
|---|---|
| Manufacturer | Healthy Life Pharma Pvt. Ltd. |
| HSN Code | 30049099 |
| Pharmacopoeia | BP |
| Product Type | Tablet |
| Category | Antitubercular drugs – Combination therapy |
| Subcategory | Combination therapy |
| Active Ingredient | Isorif |
| Strength | 300 mg + 150 mg |
| Dosage Form | Tablet |
| Pack Size | 10 x 10 Tablets / Box (Alu-Alu / Blister) |
| Route of Administration | Oral |
| Prescription Required | Yes |
| Therapeutic Category | Antitubercular drugs – Combination therapy |
Medicine Details & Safety
| Short Description | Healthy Inc invites international procurement enquiries for Isorif Tablets BP 300 mg + 150 mg manufactured by Healthy Life Pharma. Importers and overseas distributors can submit destination-country requirements for assessment of registration documentation, export artwork and shipment feasibility. | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Approved Uses / Indications | 1. First-line multidrug treatment of pulmonary and extrapulmonary tuberculosis. 2. Prophylaxis and latent tuberculosis infection management in high-risk individuals. | ||||||||||||||||||||||||
| Full Description | Healthy Inc invites international procurement enquiries for Isorif Tablets BP 300 mg + 150 mg manufactured by Healthy Life Pharma. Importers and overseas distributors can submit destination-country requirements for assessment of registration documentation, export artwork and shipment feasibility. Product technical specifications
Product technical specifications
Export regulatory and dossier readinessIdentify the destination authority and registration pathway. Request confirmation of CTD or ACTD dossier availability, COPP, Free Sale Certificate and current GMP documentation as applicable. Confirm COA and analytical files for the proposed product and market.Climatic zone stability and export artworkFor Isorif Tablets BP 300 mg + 150 mg, request stability evidence appropriate to the importing market, including Zone IVb where required. Confirm shelf life, storage conditions and multilingual carton, blister and leaflet artwork against approved documentation.Global logistics and trade termsSpecify the destination, shipment size and required delivery window. Evaluate air freight or LCL/FCL sea freight from Mumbai where feasible. Agree EXW, FOB, CIF or CIP as appropriate to the transport mode and contract; confirm freight, insurance and customs responsibilities.International buyer requirementsEnquiries may identify Africa, LATAM, Middle East, CIS or APAC as target regions. Market authorization, import permits, document availability and shipment acceptance must be confirmed for each country; this is not a statement of existing registrations. | ||||||||||||||||||||||||
| Dosage Instructions | Administer orally as a single daily dose on an empty stomach (at least 30 minutes before meals or 2 hours after meals) with water. Ensure continuous daily administration under directly observed therapy protocols. | ||||||||||||||||||||||||
| Side Effects | Common: Gastrointestinal distress, anorexia, nausea, orange-red discoloration of body fluids, mild transaminase rise. Uncommon: Peripheral neuropathy, arthralgia, headache, dizziness, cutaneous flushing. Rare: Drug-induced hepatotoxicity, optic neuritis, thrombocytopenia, hemolytic anemia. | ||||||||||||||||||||||||
| Warnings and Precautions | Hepatic Function Surveillance: Baseline and monthly liver function tests are recommended; immediately discontinue if transaminases exceed 3-5 times normal. Neuropathy Prophylaxis: Co-administer pyridoxine (vitamin B6) in patients susceptible to peripheral neuritis. Adherence: Strict uninterrupted compliance is vital to prevent MDR-TB emergence. | ||||||||||||||||||||||||
| Contraindications | 1. Hypersensitivity to Isorif or related hydrazide/rifamycin antimycobacterial drugs. 2. Severe acute liver disease or preexisting drug-induced hepatitis. 3. Severe peripheral neuropathy or preexisting optic neuritis (for ethambutol). | ||||||||||||||||||||||||
| Drug Interactions | 1. Potent CYP Inducers/Substrates: Rifamycin derivatives accelerate hepatic metabolism of oral contraceptives, warfarin, and protease inhibitors. 2. Antacids: Aluminum hydroxide decreases antimycobacterial absorption; space dosing by 2 hours. 3. Hepatotoxic Drugs & Alcohol: Compounded risk of severe hepatic necrosis. |
Frequently Asked Questions
| Question | Answer |
|---|---|
| Which registration documents can be requested for Isorif Tablets BP 300 mg + 150 mg? | Specify CTD/ACTD, COPP, FSC, COA and stability requirements for availability review. |
| Is Zone IVb data available for Isorif Tablets BP 300 mg + 150 mg? | Request confirmation for the exact formulation and packaging configuration. |
| Can export artwork be multilingual for Isorif Tablets BP 300 mg + 150 mg? | Provide the required languages and approved regulatory artwork for review. |
| Which shipping terms can be discussed for Isorif Tablets BP 300 mg + 150 mg? | EXW, FOB, CIF and CIP may be evaluated according to shipment mode and agreement. |
| How do I obtain an export quotation for Isorif Tablets BP 300 mg + 150 mg? | Provide destination country, quantity, documentation requirements and preferred trade terms. |
Related Products
✚
Isorif Tablets BP 300 mg + 150 mg ManufacturerView product →
✚
Isorif Tablets BP 300 mg + 150 mg SupplierView product →
✚
Healthy Kit Tablets BP 20 mg + 1.5 g + 2.9 g ExporterView product →
✚
Healthy Kit Tablets BP 20 mg + 1.5 g + 2.9 g ManufacturerView product →
✚
Healthy Kit Tablets BP 20 mg + 1.5 g + 2.9 g SupplierView product →
✚
Rip Tablets BP 150 mg + 75 mg + 400 mg ExporterView product →
✚
Rip Tablets BP 150 mg + 75 mg + 400 mg ManufacturerView product →
✚
Rip Tablets BP 150 mg + 75 mg + 400 mg SupplierView product →
✚
Ripe Tablets BP 150 mg + 75 mg + 400 mg ExporterView product →
✚
Ripe Tablets BP 150 mg + 75 mg + 400 mg ManufacturerView product →
✚
Ripe Tablets BP 150 mg + 75 mg + 400 mg SupplierView product →
Latest Posts
✚
What are acarbose tablets used for?Read article →✚
amikacin injection product usageRead article →✚
bharat-s-leading-pharmaceutical-manufacturerRead article →✚
india's leading pharmaceutical manufacturerRead article →✚
WHO GMP certfied Hydralazine hydrochloride Tablets ManufacturerRead article →✚
WHO GMP certfied Haloperidol Tablets ManufacturerRead article →✚
WHO GMP certfied Griseofulvin Tablets ManufacturerRead article →✚
WHO GMP certfied Glyceryl Trinitrate Tablets ManufacturerRead article →